Part I: Detection and Characterization of Viral Pathogens with Microfluidics-Based Genomic Analysis (Bill Hunt, MS, Director, Microfluidics Product Management, Fluidigm).

Part II: Detection of Human and Viral Full-Length RNA Using a Nanoscale Microfluidic Platform (Steve Kain, PhD, MBA, Director, Genomics Product Management, Fluidigm).

свернуть